US Stock MarketDetailed Quotes

CERo Therapeutics (CERO)

Watchlist
  • 0.0343
  • -0.0007-2.00%
15min DelayClose Apr 24 15:53 ET
1.26MMarket Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CERo Therapeutics (CERO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
19.33M
4.43M
-0.90%4.36M
5.49%5.43M
5.11M
186.68%4.4M
113.29%5.15M
-35.89%7.68M
1.12M
1.54M
Selling and administrative expenses
--8.94M
--2.09M
-24.80%1.98M
9.99%2.68M
--2.2M
918.56%2.63M
99.39%2.43M
12.27%2.39M
--103.07K
--258.01K
-General and administrative expense
--8.94M
--2.09M
-24.80%1.98M
9.99%2.68M
--2.2M
918.56%2.63M
99.39%2.43M
12.27%2.39M
--103.07K
--258.01K
Research and development costs
--10.38M
--2.33M
34.50%2.39M
1.46%2.75M
--2.91M
38.88%1.77M
127.51%2.71M
-46.28%5.29M
--1.02M
--1.28M
Operating profit
-19.33M
-4.43M
0.90%-4.36M
-5.49%-5.43M
-5.11M
-186.68%-4.4M
-113.29%-5.15M
35.89%-7.68M
-1.12M
-1.54M
Net non-operating interest income expense
11.61K
-8.95K
34.36%5.94K
181.15%13.78K
850
2,714.01%4.42K
-128.57%-16.98K
-2.66%138.34K
20.09K
157
Non-operating interest income
--11.61K
----
----
----
--850
2,714.01%4.42K
----
-2.66%138.34K
--20.09K
--157
Non-operating interest expense
----
----
----
----
----
----
--16.98K
----
----
----
Total other finance cost
----
----
-34.36%-5.94K
-181.15%-13.78K
----
---4.42K
--16.98K
----
----
----
Other net income (expense)
-605.18K
-105.43K
-394.23%-499.75K
-8.71%169.85K
937.56%2.72M
247.13K
-164.1K
186.07K
Gain on sale of security
----
----
----
----
----
-8.64%170K
1,007.62%2.9M
--301.17K
---110.06K
--186.07K
Special income (charges)
---605.42K
---105.42K
-394.12%-500K
--0
--0
--170K
--447.34K
--8.14K
----
----
-Less：Restructuring and merger&acquisition
----
----
--0
----
--0
---170K
----
----
----
----
-Less:Other special charges
----
----
----
----
----
----
---447.34K
---8.14K
----
----
-Write off
--605.42K
--105.42K
--500K
----
----
--0
----
----
----
----
Other non- operating income (expenses)
--242
---6
268.71%248
----
----
---147
---630.78K
---62.18K
----
----
Income before tax
-19.92M
-4.54M
-14.86%-4.86M
-121.24%-5.42M
-5.11M
-213.33%-4.23M
-17.02%-2.45M
38.38%-7.29M
-1.27M
-1.35M
Income tax
Net income
-19.92M
-4.54M
-14.86%-4.86M
-121.24%-5.42M
-5.11M
-213.33%-4.23M
-17.02%-2.45M
38.38%-7.29M
-1.27M
-1.35M
Net income continuous Operations
---19.92M
---4.54M
-14.86%-4.86M
-121.24%-5.42M
---5.11M
-213.33%-4.23M
-17.02%-2.45M
38.38%-7.29M
---1.27M
---1.35M
Minority interest income
Net income attributable to the parent company
-19.92M
-4.54M
-14.86%-4.86M
-121.24%-5.42M
-5.11M
-213.33%-4.23M
-17.02%-2.45M
38.38%-7.29M
-1.27M
-1.35M
Preferred stock dividends
75.52M
43.91M
6.65M
24.7M
264.14K
Other preferred stock dividends
84.08K
0
0
0
84.08K
0
0
0
Net income attributable to common stockholders
-95.53M
-48.45M
-172.15%-11.51M
-1,129.97%-30.12M
-5.45M
-213.33%-4.23M
-17.02%-2.45M
38.38%-7.29M
-1.27M
-1.35M
Basic earnings per share
-22.58
-2.2958
94.65%-9.1
79.59%-61.71
-31.8
35.08%-170.22
34.28%-302.32
45.74%-1.42K
-245.8574
-262.2128
Diluted earnings per share
-22.58
-2.2958
94.65%-9.1
79.59%-61.71
-31.8
35.08%-170.22
34.28%-302.32
45.74%-1.42K
-245.8574
-262.2128
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(Q3)Sep 30, 2024(Q2)Jun 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 19.33M4.43M-0.90%4.36M5.49%5.43M5.11M186.68%4.4M113.29%5.15M-35.89%7.68M1.12M1.54M
Selling and administrative expenses --8.94M--2.09M-24.80%1.98M9.99%2.68M--2.2M918.56%2.63M99.39%2.43M12.27%2.39M--103.07K--258.01K
-General and administrative expense --8.94M--2.09M-24.80%1.98M9.99%2.68M--2.2M918.56%2.63M99.39%2.43M12.27%2.39M--103.07K--258.01K
Research and development costs --10.38M--2.33M34.50%2.39M1.46%2.75M--2.91M38.88%1.77M127.51%2.71M-46.28%5.29M--1.02M--1.28M
Operating profit -19.33M-4.43M0.90%-4.36M-5.49%-5.43M-5.11M-186.68%-4.4M-113.29%-5.15M35.89%-7.68M-1.12M-1.54M
Net non-operating interest income expense 11.61K-8.95K34.36%5.94K181.15%13.78K8502,714.01%4.42K-128.57%-16.98K-2.66%138.34K20.09K157
Non-operating interest income --11.61K--------------8502,714.01%4.42K-----2.66%138.34K--20.09K--157
Non-operating interest expense --------------------------16.98K------------
Total other finance cost ---------34.36%-5.94K-181.15%-13.78K-------4.42K--16.98K------------
Other net income (expense) -605.18K-105.43K-394.23%-499.75K-8.71%169.85K937.56%2.72M247.13K-164.1K186.07K
Gain on sale of security ---------------------8.64%170K1,007.62%2.9M--301.17K---110.06K--186.07K
Special income (charges) ---605.42K---105.42K-394.12%-500K--0--0--170K--447.34K--8.14K--------
-Less：Restructuring and merger&acquisition ----------0------0---170K----------------
-Less:Other special charges ---------------------------447.34K---8.14K--------
-Write off --605.42K--105.42K--500K----------0----------------
Other non- operating income (expenses) --242---6268.71%248-----------147---630.78K---62.18K--------
Income before tax -19.92M-4.54M-14.86%-4.86M-121.24%-5.42M-5.11M-213.33%-4.23M-17.02%-2.45M38.38%-7.29M-1.27M-1.35M
Income tax
Net income -19.92M-4.54M-14.86%-4.86M-121.24%-5.42M-5.11M-213.33%-4.23M-17.02%-2.45M38.38%-7.29M-1.27M-1.35M
Net income continuous Operations ---19.92M---4.54M-14.86%-4.86M-121.24%-5.42M---5.11M-213.33%-4.23M-17.02%-2.45M38.38%-7.29M---1.27M---1.35M
Minority interest income
Net income attributable to the parent company -19.92M-4.54M-14.86%-4.86M-121.24%-5.42M-5.11M-213.33%-4.23M-17.02%-2.45M38.38%-7.29M-1.27M-1.35M
Preferred stock dividends 75.52M43.91M6.65M24.7M264.14K
Other preferred stock dividends 84.08K00084.08K000
Net income attributable to common stockholders -95.53M-48.45M-172.15%-11.51M-1,129.97%-30.12M-5.45M-213.33%-4.23M-17.02%-2.45M38.38%-7.29M-1.27M-1.35M
Basic earnings per share -22.58-2.295894.65%-9.179.59%-61.71-31.835.08%-170.2234.28%-302.3245.74%-1.42K-245.8574-262.2128
Diluted earnings per share -22.58-2.295894.65%-9.179.59%-61.71-31.835.08%-170.2234.28%-302.3245.74%-1.42K-245.8574-262.2128
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes------------------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -